.
New Delhi, April 21 (MondayMirror.com) The expert panel of India’s apex drug regulator on Thursday recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.
According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E’s Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.
Earlier in the day, the panel held a meeting to discuss the recommendations on restricted emergency use of Bharat Biotech’s Covaxin and Biological E’s Corbevax vaccines among children aged 5-12.
The SEC has sent the recommendations to the DCGI. After the DCGI’s nod to the recommendation, the Union Health Ministry may give final approval to begin the vaccination for this age group.
Corbevax vaccine is India’s first indigenously-developed protein sub-unit vaccine against Covid-19. This vaccine is currently being administered to children in the age group 12-14 years.
Source: IANS
Bollywood star Vicky Kaushal recently took to his social media account to warmly wish his…
Aamir Khan's production banner, Aamir Khan Productions, shared a video on their social media account…
Bollywood superstar Salman Khan has taken the internet by storm with his shirtless picture that…
Assam Chief Minister Himanta Biswa Sarma's claim on Monday that popular singer Zubeen Garg's death…
Bollywood’s young star Suhana Khan, daughter of Shah Rukh Khan, is again in the spotlight.…
Filmmaker Ram Gopal Varma will soon be treating the movie buffs with his forthcoming horror…